Lv2
120 积分 2024-07-23 加入
Update on the pathophysiology and treatment of primary Sjögren syndrome
4天前
已完结
Efficacy and safety of pharmacological treatment for Sjögren’s disease: a network meta-analysis
6天前
已完结
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
10天前
已完结
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
10天前
已完结
The colorectal cancer drug market
25天前
已完结
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Rα with a Biparatopic nanobody
1个月前
已完结
Nonclinical Immunogenicity Risk Assessment of Therapeutic Proteins
1个月前
已完结
Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
4个月前
已完结
IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein
5个月前
已完结
皖公网安备34019202002308
